Position in GSK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$19,500
-$429,856 QoQ
Shares Held
372
-96.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#886
of 1,032 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GFS Advisors, LLC holds $987,567 across 10 Drug Manufacturers - General names. GSK ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
300 | $359,829 | |
| 2 | NVO |
Novo Nordisk A S
|
5,840 | $279,969 | |
| 3 | JNJ |
Johnson & Johnson
|
46,182 | $143,960 | |
| 4 | ABBV |
AbbVie Inc.
|
10,263 | $143,938 | |
| 5 | GSK |
GSK plc
This page
|
372 | $19,500 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,710 | $18,634 | |
| 7 | OGN |
Organon & Co.
|
1,267 | $17,155 | |
| 8 | MRK |
Merck & Co., Inc.
|
79,011 | $3,361 |
All Filings in GSK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,500 | 372 | Shares | Sole | 2026-08-04 | |
| 2022-06-30 | $449,356 | 10,525 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $477,864 | 11,185 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $527,041 | 12,185 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $413,551 | 11,035 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $430,976 | 11,035 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $386,277 | 11,035 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $398,291 | 11,035 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $407,382 | 11,035 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $441,475 | 11,035 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $410,088 | 11,035 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||